128 related articles for article (PubMed ID: 12771942)
1. REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells.
Oosterhoff JK; Penninkhof F; Brinkmann AO; Anton Grootegoed J; Blok LJ
Oncogene; 2003 May; 22(19):2920-5. PubMed ID: 12771942
[TBL] [Abstract][Full Text] [Related]
2. EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2.
Oosterhoff JK; Kühne LC; Grootegoed JA; Blok LJ
Int J Cancer; 2005 Feb; 113(4):561-7. PubMed ID: 15455380
[TBL] [Abstract][Full Text] [Related]
3. Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors.
Nakashima S; Morinaka K; Koyama S; Ikeda M; Kishida M; Okawa K; Iwamatsu A; Kishida S; Kikuchi A
EMBO J; 1999 Jul; 18(13):3629-42. PubMed ID: 10393179
[TBL] [Abstract][Full Text] [Related]
4. Identification of REPS2 as a putative modulator of NF-kappaB activity in prostate cancer cells.
Penninkhof F; Grootegoed JA; Blok LJ
Oncogene; 2004 Jul; 23(33):5607-15. PubMed ID: 15184881
[TBL] [Abstract][Full Text] [Related]
5. Epsin binds to the EH domain of POB1 and regulates receptor-mediated endocytosis.
Morinaka K; Koyama S; Nakashima S; Hinoi T; Okawa K; Iwamatsu A; Kikuchi A
Oncogene; 1999 Oct; 18(43):5915-22. PubMed ID: 10557078
[TBL] [Abstract][Full Text] [Related]
6. The central proline rich region of POB1/REPS2 plays a regulatory role in epidermal growth factor receptor endocytosis by binding to 14-3-3 and SH3 domain-containing proteins.
Tomassi L; Costantini A; Corallino S; Santonico E; Carducci M; Cesareni G; Castagnoli L
BMC Biochem; 2008 Jul; 9():21. PubMed ID: 18647389
[TBL] [Abstract][Full Text] [Related]
7. Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling.
Oosterhoff JK; Grootegoed JA; Blok LJ
Endocr Relat Cancer; 2005 Mar; 12(1):135-48. PubMed ID: 15788645
[TBL] [Abstract][Full Text] [Related]
8. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).
Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC
Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
10. PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression.
Xu LL; Shi Y; Petrovics G; Sun C; Makarem M; Zhang W; Sesterhenn IA; McLeod DG; Sun L; Moul JW; Srivastava S
Cancer Res; 2003 Aug; 63(15):4299-304. PubMed ID: 12907594
[TBL] [Abstract][Full Text] [Related]
11. Exisulind and related compounds inhibit expression and function of the androgen receptor in human prostate cancer cells.
Lim JT; Piazza GA; Pamukcu R; Thompson WJ; Weinstein IB
Clin Cancer Res; 2003 Oct; 9(13):4972-82. PubMed ID: 14581372
[TBL] [Abstract][Full Text] [Related]
12. Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer.
Xiao W; Zhang Q; Jiang F; Pins M; Kozlowski JM; Wang Z
Cancer Res; 2003 Aug; 63(15):4698-704. PubMed ID: 12907652
[TBL] [Abstract][Full Text] [Related]
13. Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons.
Nagano K; Masters JR; Akpan A; Yang A; Corless S; Wood C; Hastie C; Zvelebil M; Cramer R; Naaby-Hansen S
Oncogene; 2004 Mar; 23(9):1693-703. PubMed ID: 14647428
[TBL] [Abstract][Full Text] [Related]
14. Evolution of the androgen receptor pathway during progression of prostate cancer.
Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
[TBL] [Abstract][Full Text] [Related]
15. Regulation of growth hormone receptors in human prostate cancer cell lines.
Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
Mol Cell Endocrinol; 2009 Oct; 309(1-2):82-92. PubMed ID: 19540305
[TBL] [Abstract][Full Text] [Related]
16. Rap2 regulates androgen sensitivity in human prostate cancer cells.
Bigler D; Gioeli D; Conaway MR; Weber MJ; Theodorescu D
Prostate; 2007 Oct; 67(14):1590-9. PubMed ID: 17918750
[TBL] [Abstract][Full Text] [Related]
17. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
[TBL] [Abstract][Full Text] [Related]
18. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
Arnoldussen YJ; Lorenzo PI; Pretorius ME; Waehre H; Risberg B; Maelandsmo GM; Danielsen HE; Saatcioglu F
Cancer Res; 2008 Nov; 68(22):9255-64. PubMed ID: 19010898
[TBL] [Abstract][Full Text] [Related]
19. Proteomic identification of 14-3-3 sigma as a common component of the androgen receptor and the epidermal growth factor receptor signaling pathways of the human prostate epithelial cell line M12.
Huang D; Liu X; Plymate SR; Idowu M; Grimes M; Best AM; McKinney JL; Ware JL
Oncogene; 2004 Sep; 23(41):6881-9. PubMed ID: 15300238
[TBL] [Abstract][Full Text] [Related]
20. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer.
Chang GT; Jhamai M; van Weerden WM; Jenster G; Brinkmann AO
Endocr Relat Cancer; 2004 Dec; 11(4):815-22. PubMed ID: 15613454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
